Clinical trial
PRESEPSIN: Biomarker in the Early Diagnosis of Sepsis
NCT06180265 is registered in ClinicalTrials.gov with University of Foggia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PRESEPSIN: Biomarker in the Early Diagnosis of Sepsis
- Lead sponsor
- University of Foggia
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 1, 2020
- Completion date
- July 19, 2023
- Enrollment
- 90 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
septic shock